Skip to Content

Everolimus

In the US, Everolimus (everolimus systemic) is a member of the following drug classes: mTOR inhibitors, selective immunosuppressants and is used to treat Brain Tumor, Breast Cancer, Neuroendocrine Carcinoma, Organ Transplant - Rejection Prophylaxis, Pancreatic Cancer, Renal Angiomyolipoma, Renal Cell Carcinoma, Subependymal Giant Cell Astrocytoma and Tuberous Sclerosis.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XE10,L04AA18

CAS registry number (Chemical Abstracts Service)

0159351-69-6

Chemical Formula

C53-H83-N-O14

Molecular Weight

958

Therapeutic Category

Selective immunosuppressant

Chemical Name

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyetoxyl)-3-metoxycyclohexyl]-1-metyletyl]-10,21-dimetoxy-6,8,12,14,20,26-hexametyl-23, (WHO)

Foreign Names

  • Everolimusum (Latin)
  • Everolimus (German)
  • √Čv√©rolimus (French)
  • Everolimus (Spanish)

Generic Names

  • Everolimus (OS: USAN, BAN, JAN)
  • RAD 001 (IS: Novartis)
  • SDZ-RAD (IS: Novartis)

Brand Names

  • Afinitor
    Novartis, Bosnia & Herzegowina; Novartis, Belgium; Novartis, Chile; Novartis, China; Novartis, Czech Republic; Novartis, Egypt; Novartis, Finland; Novartis, France; Novartis, Georgia; Novartis, Greece; Novartis, Hong Kong; Novartis, Croatia (Hrvatska); Novartis, Hungary; Novartis, Indonesia; Novartis, Ireland; Novartis, Israel; Novartis, Iceland; Novartis, Japan; Novartis, South Korea; Novartis, Lithuania; Novartis, Latvia; Novartis, Macedonia; Novartis, Mexico; Novartis, Norway; Novartis, New Zealand; Novartis, Oman; Novartis, Poland; Novartis, Romania; Novartis, Serbia; Novartis, Sweden; Novartis, Slovenia; Novartis, Slovakia; Novartis, Thailand; Novartis, Turkey; Novartis, Taiwan; Novartis, United States; Novartis AH, South Africa; Novartis Europharm, Austria; Novartis Europharm, Cyprus; Novartis Europharm, Denmark; Novartis Farma, Italy; Novartis Farmaceutica, Spain; Novartis Healthcare, Philippines; Novartis Pharma, Switzerland; Novartis Pharma, Germany; Novartis Pharmaceuticals, Australia; Novartis Pharmaceuticals, Canada; Novartis Pharmaceuticals UK, United Kingdom
  • Certican
    Euro Registratie, Netherlands; Fisher Farma, Netherlands; Novartis, Argentina; Novartis, Bosnia & Herzegowina; Novartis, Belgium; Novartis, Bulgaria; Novartis, Chile; Novartis, Czech Republic; Novartis, Denmark; Novartis, Ecuador; Novartis, Estonia; Novartis, Egypt; Novartis, Finland; Novartis, France; Novartis, Georgia; Novartis, Greece; Novartis, Hong Kong; Novartis, Croatia (Hrvatska); Novartis, Hungary; Novartis, Indonesia; Novartis, Israel; Novartis, Iceland; Novartis, Japan; Novartis, South Korea; Novartis, Lebanon; Novartis, Lithuania; Novartis, Latvia; Novartis, Macedonia; Novartis, Malta; Novartis, Mexico; Novartis, Malaysia; Novartis, Netherlands; Novartis, Norway; Novartis, Oman; Novartis, Poland; Novartis, Portugal; Novartis, Romania; Novartis, Serbia; Novartis, Sweden; Novartis, Slovakia; Novartis, Thailand; Novartis, Turkey; Novartis, Taiwan; Novartis, Venezuela; Novartis AH, South Africa; Novartis Farma, Italy; Novartis Farmaceutica, Spain; Novartis Healthcare, Philippines; Novartis Pharma, Austria; Novartis Pharma, Switzerland; Novartis Pharma, Germany; Novartis Pharma, Vietnam; Novartis Pharmaceuticals, Australia; Novartis Pharmaceuticals, Cyprus; Novartis Pharmaceuticals UK, United Kingdom
  • Votubia
    Novartis, Bosnia & Herzegowina; Novartis, Denmark; Novartis, Finland; Novartis, France; Novartis, Croatia (Hrvatska); Novartis, Hungary; Novartis, Lithuania; Novartis, Latvia; Novartis, Netherlands; Novartis, Norway; Novartis, Poland; Novartis, Portugal; Novartis, Romania; Novartis, Sweden; Novartis, Slovakia; Novartis Europharm, Austria; Novartis Europharm, Greece; Novartis Europharm, Slovenia; Novartis Farmaceutica, Spain; Novartis Pharma, Switzerland; Novartis Pharma, Germany; Novartis Pharmaceuticals UK, United Kingdom
  • Zortress
    Novartis, United States

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide